In ARCTIC , @ patients were randomized before coronary stenting to a strategy of platelet function monitoring ( VerifyNow P@Y@/aspirin point-of-care assay ) with drug adjustment in suboptimal responders to antiplatelet therapy or to a conventional strategy without monitoring and without drug or dose changes .